The study is compelling, for over 65 years, the people that have been vaccinated with two doses of the COVID-19 vaccine but the disease has not passed of the coronavirus, those people, will need a third dose sooner. If those people over 65 have not passed the coronavirus, immunity collapses.
What the study says
“Our study says that it has been carried out in 100 people over 65 years of age that those who have received the vaccine but had not previously suffered from the disease have a lower response than those who had passed the disease and were vaccinated,” he explains. Buenaventura Clotet, author of the study, on the low immunity of the elderly.
The researcher assures in the program Espejo Público of Antena 3 Noticias that “people who had been infected and vaccinated against COVID-19 with 2 doses at three months had correct immunity levels, while people over 65 who had only been vaccinated and had not suffered from the disease had very low levels of protective antibodies, neutralizing antibodies. “
Prioritize the 3rd dose in people over 65 years of age
“This has to lead us to prioritize for when we start giving the 3rd dose to all those people over 65 years of age, especially those over 80 who receive the 3rd dose. In the first place, those who had only received 2 doses of vaccines but they had not had the disease. That is important when it comes to structuring how these people are treated and prioritizing vaccines, their destination “has indicated Buenaventura Clotet, author of the study on the low immunity of the elderly.
The people over 65 who have passed the covid have high protective antibody levels 3 months after receiving the COVID-19 vaccine, unlike those who did not pass the disease, according to a study by IrsiCaixa and the North Metropolitan Primary Care of the Catalan Institute of Health (ICS).
The study points that neutralizing antibody levels of this group of older people are high, compared to those vaccinated who have not had the disease. The research team has observed that vaccinated older people who had previously passed the infection, although they have a less effective immune response, achieve antibody levels similar to those of younger people.
–
